The 2nd edition of this book describes the recent techniques, strategies, and drugs that have been demonstrated by multicenter randomized trials to influence survival in critically ill, defined as those who have acute failure of at least one organ, due to either a pathological condition or a medical intervention, and require intensive care treatment. Each chapter focuses on a specific procedure, device, or drug. The scope is accordingly wide, with coverage of topics as diverse as noninvasive mechanical ventilation, protective ventilation, prone positioning, intravenous salbutamol in ARDS,…mehr
The 2nd edition of this book describes the recent techniques, strategies, and drugs that have been demonstrated by multicenter randomized trials to influence survival in critically ill, defined as those who have acute failure of at least one organ, due to either a pathological condition or a medical intervention, and require intensive care treatment. Each chapter focuses on a specific procedure, device, or drug. The scope is accordingly wide, with coverage of topics as diverse as noninvasive mechanical ventilation, protective ventilation, prone positioning, intravenous salbutamol in ARDS, high-frequency oscillatory ventilation, mild hypothermia after cardiac arrest, daily interruption of sedatives, tranexamic acid, diaspirin cross-linked hemoglobin, albumin, growth hormone, glutamine supplementation, tight glucose control, supranormal oxygen delivery, and hydroxyethyl starch in sepsis. The topics selection was performed with the help of hundreds of specialists from dozens of countries; they expressed via web if they agreed or not with these topics and if they used them in their daily clinical practice. The clear text is supported by "how to do" sections and "key point" boxes that provide easily accessible practical information. Written by acknowledged international experts, Reducing Mortality in Critically Ill Patients is of interest for a wide variety of specialists, including intensivists, emergency doctors, and anesthesiologists.
Giovanni Landoni is currently Associate Professor at Vita-Salute San Raffaele University, Milan, where he works as Director Center for Intensive Care and Anesthesiology San Raffaele Scientific Institute. He participated to ideation, writing and implementation of more than 20 grants that got funding from national and international donors. He served as reviewer for over 50 journals (NEJM, JAMA, The Lancet, British Medical Journal, Circulation and Intensive Care Medicine among others) and for foreign grant agencies. Prof Landoni was Chief Investigator in successfully completed multicenter randomized clinical trials that enrolled > 5,000 critically ill or perioperative patients over the last 5 years and were published in the NEJM. He ideated, organized and published the findings of the innovative web based International Consensus Conferences with thousands of participants from over 70 countries. Martina Baiardo Redaelli MD, Anesthesia and Intensive Care Physician at San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy. Chiara Sartini MD, Anesthesia and Intensive Care Physician at San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy. Alberto Zangrillo is Full Professor in Anesthesiology and Intensive Care and Head of Anesthesia and Intensive Care at San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy, the largest Italian surgical hospital. He's Vice-rector for clinical activities, Vita-Salute San Raffaele, Milan and Chief Physician of San Raffaele Scientific Institute. Dr. Zangrillo is among the world's top 10 fastest publishing clinical scientists in the field of intensive care and anesthes. He was Vice-Chairman of the National Research Committee (CNR) and Chairman of the IInd Committee of the Supreme Public Health Council. He was decorated with the title ofKnight of the Order of Merit of the Italian Republic by President of the Republic in June 2004 and with the title of Commander by President of the Republic, Giorgio Napolitano, in December 2010. Rinaldo Bellomo is Director of Intensive Care Research at Austin Health, Director of the Data Analytics Research and Evaluation Centre of the University of Melbourne and of the Centre for Integrated Critical Care at the University of Melbourne and Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC). He is Professor of Intensive care with the University of Melbourne and Honorary Professor, Faculty of Medicine, Monash University, and holds further leading academic positions in Australia and overseas. In 2014, Professor Bellomo was named in Thomson Reuters the World's Most Influential Scientific Minds 2014. He has been on the list of most cited investigators in Medicine for the last 7 years. In 2018 he received the Order of Australia for his contribution to Medicine. Professor Bellomo has published more than 1300 papers, written more than 180 book chapters, and edited 15 books in the field of intensive care medicine. He is Editor-in-Chief of Critical Care and Resuscitation. Over the past 10 years, he has been heavily involved in the design, execution, supervision, and publication of several large randomized controlled trials published in the New England Journal of Medicine, Lancet and JAMA.
Inhaltsangabe
The process of consensus building.- Non-invasive ventilation.- High Flow Nasal Cannulae.- Restrictive inspiratory oxygen fraction.- Mechanical ventilation.- Early tracheostomy.- Pharmacological Managment of cardiac arrest.- Non pharmacological Managment of cardiac arrest.- Avoidance of deep sedation.- Hydrocortisone in sepsis; Goal directed therapy.- Levosimendan in cardiogenic shock and low cardiac output syndrome.- Drugs in myocardial infarction.- Tranexamic acid in trauma patients.- Procalcitonin-guided antibiotic discontinuation.- Selective decontamination of digestive tract.- Nutrition.- ECMO.- Ultrasound.- Alternative medicine.- Interventions increasing mortality.- Conflicting.- Latest evidences.
The process of consensus building.- Non-invasive ventilation.- High Flow Nasal Cannulae.- Restrictive inspiratory oxygen fraction.- Mechanical ventilation.- Early tracheostomy.- Pharmacological Managment of cardiac arrest.- Non pharmacological Managment of cardiac arrest.- Avoidance of deep sedation.- Hydrocortisone in sepsis; Goal directed therapy.- Levosimendan in cardiogenic shock and low cardiac output syndrome.- Drugs in myocardial infarction.- Tranexamic acid in trauma patients.- Procalcitonin-guided antibiotic discontinuation.- Selective decontamination of digestive tract.- Nutrition.- ECMO.- Ultrasound.- Alternative medicine.- Interventions increasing mortality.- Conflicting.- Latest evidences.
The process of consensus building.- Non-invasive ventilation.- High Flow Nasal Cannulae.- Restrictive inspiratory oxygen fraction.- Mechanical ventilation.- Early tracheostomy.- Pharmacological Managment of cardiac arrest.- Non pharmacological Managment of cardiac arrest.- Avoidance of deep sedation.- Hydrocortisone in sepsis; Goal directed therapy.- Levosimendan in cardiogenic shock and low cardiac output syndrome.- Drugs in myocardial infarction.- Tranexamic acid in trauma patients.- Procalcitonin-guided antibiotic discontinuation.- Selective decontamination of digestive tract.- Nutrition.- ECMO.- Ultrasound.- Alternative medicine.- Interventions increasing mortality.- Conflicting.- Latest evidences.
The process of consensus building.- Non-invasive ventilation.- High Flow Nasal Cannulae.- Restrictive inspiratory oxygen fraction.- Mechanical ventilation.- Early tracheostomy.- Pharmacological Managment of cardiac arrest.- Non pharmacological Managment of cardiac arrest.- Avoidance of deep sedation.- Hydrocortisone in sepsis; Goal directed therapy.- Levosimendan in cardiogenic shock and low cardiac output syndrome.- Drugs in myocardial infarction.- Tranexamic acid in trauma patients.- Procalcitonin-guided antibiotic discontinuation.- Selective decontamination of digestive tract.- Nutrition.- ECMO.- Ultrasound.- Alternative medicine.- Interventions increasing mortality.- Conflicting.- Latest evidences.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309